We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Confirms Recommendation to Suspend Drugs Over Flawed Studies
EMA Confirms Recommendation to Suspend Drugs Over Flawed Studies
The European Medicines Agency has confirmed plans to halt sales of 700 drug forms and strengths authorized based on clinical studies performed by Hyderabad, India-based GVK Biosciences.